Orbimed Advisors LLC Red Hill Biopharma Ltd. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$6.06 - $9.0 $330,876 - $491,400	-54,600 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$5.18 - $9.35 $1.19 Million - $2.15 Million	-230,300 Reduced 80.84%	54,600 $303,000
Q3 2018 Nov 14, 2018	SELL	$6.0 - $11.35 $1.68 Million - $3.18 Million	-280,000 Reduced 49.57%	284,900 $2.52 Million
Q3 2017 Nov 14, 2017	BUY	$8.25 - $10.81 $4.66 Million - $6.11 Million	564,900	564,900 $6.11 Million

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.